KDM5B and neoplasm: A recent analysis characterized the tumor and immune microenvironment incorporating digital spatial profiling in pre- and post-treatment tumors from the PURE01 to identify the histone demethylase KDM5B as a repressor of tumor-immune signaling pathways [34].